EXO-50 — Exosomes · Wharton’s Jelly · Topical & Systemic
Exosomes are membrane-bound extracellular vesicles that carry protected biological information — growth factors, signalling proteins, and intercellular communication — in a form the body recognises as its own. They restore the signals the body once produced in abundance and has progressively lost over time. Where pharmaceuticals override biological processes, exosomes restore the conditions in which the body’s own processes can express themselves fully.
EXO-50 is the foundational Wharton’s jelly–derived systemic exosome formulation. At 50 billion exosomes it bridges topical and systemic application — carrying the biological language of connective tissue, structural matrix communication, and tissue repair coordination into both surface-level and internal environments. It is reconstituted with copper peptide solution for topical delivery or administered systemically depending on the clinical indication.
EXO-50 is the most versatile formulation in the Wharton’s jelly line — used across regenerative aesthetics, musculoskeletal protocols, and as the signalling component of the small joint protocol alongside WJ-95. It is the entry point into systemic Wharton’s jelly–derived biological support and the foundational formulation for connective tissue environments throughout the body.
Specifications
Concentration: 50B exosomes · Volume: 5mL · Format: Lyophilised · Reconstitution: Copper Peptide Solution · Source: Wharton’s Jelly · Access: Consumer & Clinical
Manufactured by Platinum Biologics. US donors. Full pathogen screening. COA on every batch.
